• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corporation Common Stock (NY:GKOS)

    120.47 +0.98 (+0.82%)
    Streaming Delayed Price Updated: 12:32 PM EDT, Apr 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Glaukos Corporation Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    News headline image
    Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗
    Via Chartmill
    News headline image
    Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
    This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions. 
    Via The Motley Fool
    Topics Regulatory Compliance
    Glaukos Corp (NYSE:GKOS) Reports Record 2025 Sales but Shares Dip on Wider Loss, Conservative Outlook ↗
    Via Chartmill
    News headline image
    Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
    Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
    This UK-based biotech advances clinical-stage therapies for rare diseases, targeting specialty care markets with a diversified pipeline. 
    Via The Motley Fool
    News headline image
    CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
    This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients with limited treatment options. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
    BrightSpring Health Services delivers integrated pharmacy and clinical care to Medicare, Medicaid, and insured patients nationwide. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Glaukos (GKOS) Q4 2025 Earnings Call Transcript ↗
    Glaukos (GKOS) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Director Sells GKOS 15,000 Shares for $1.9 Million ↗
    This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
    From Glaukos Corporation
    Via Business Wire
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Participation in J.P. Morgan Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗
    Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗
    The company's recent past featured robust growth, and it anticipates continued rises into the near future. 
    Via The Motley Fool
    News headline image
    Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗
    Glaukos (GKOS) Q3 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
     
    Via Benzinga
    News headline image
    Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Why Glaukos Stock Jumped Over 20% After-Hours Today ↗
    Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance. 
    Via Stocktwits
    News headline image
    What's going on in today's after hours session ↗
    The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
    Via Chartmill
    News headline image
    Glaukos Corp (NYSE:GKOS) Soars on Strong Q3 2025 Earnings Beat and Robust 2026 Outlook ↗
    Glaukos (GKOS) smashed Q3 2025 earnings forecasts, sending its stock soaring. The company posted record revenue and raised its 2025 and 2026 sales guidance. 
    Via Chartmill
    Topics Earnings
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.